Consistent with their role in breast cancer progression, high levels of MMP-2 have been found to correlate with a poor prognosis in breast cancer patients (Talvensaari-Mattila et al, 1998; Duffy et al, 2000). Here, MMP2 is linked to breast carcinoma.